These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 37300260)

  • 1. Association between Chronic Liver Disease Caused by Viral Hepatitis, Hospitalisation for COVID-19 and Mortality.
    Aslam J; Qaisar F; Khaliq M; Khalid M; Sabeeh DE; Ali AY
    J Coll Physicians Surg Pak; 2023 Jun; 33(6):647-652. PubMed ID: 37300260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Short-term outcomes of patients with chronic liver disease hospitalised with COVID-19.
    Grgurevic I; Lucijanić M; Pastrovic F; Barisic Jaman M; Tjesic Drinkovic I; Zelenika M; Milosevic M; Medic B; Kardum D; Bokun T; Luksic I; Piskac Zivkovic N; Keres T; Grabovac V; Persec J; Barsic B
    Intern Med J; 2022 Nov; 52(11):1891-1899. PubMed ID: 35555962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical characteristics and outcomes of COVID-19 in patients with autoimmune hepatitis: A population-based matched cohort study.
    Krishnan A; Patel RA; Hadi YB; Mukherjee D; Shabih S; Thakkar S; Singh S; Woreta TA; Alqahtani SA
    World J Hepatol; 2023 Jan; 15(1):68-78. PubMed ID: 36744163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of COVID-19 on patients with compensated chronic liver diseases.
    Ji D; Zhang D; Yang T; Mu J; Zhao P; Xu J; Li C; Cheng G; Wang Y; Chen Z; Qin E; Lau G
    Hepatol Int; 2020 Sep; 14(5):701-710. PubMed ID: 32734407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SARS-CoV-2 infection in patients with autoimmune hepatitis.
    Marjot T; Buescher G; Sebode M; Barnes E; Barritt AS; Armstrong MJ; Baldelli L; Kennedy J; Mercer C; Ozga AK; Casar C; Schramm C; ; Moon AM; Webb GJ; Lohse AW
    J Hepatol; 2021 Jun; 74(6):1335-1343. PubMed ID: 33508378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Colchicine for the treatment of COVID-19.
    Mikolajewska A; Fischer AL; Piechotta V; Mueller A; Metzendorf MI; Becker M; Dorando E; Pacheco RL; Martimbianco ALC; Riera R; Skoetz N; Stegemann M
    Cochrane Database Syst Rev; 2021 Oct; 10(10):CD015045. PubMed ID: 34658014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Severity of Non-B and Non-C Hepatitis Versus Hepatitis B and C Associated Chronic Liver Disease: A Retrospective, Observational, Comparative Study.
    Asghar MS; Ahsan MN; Rasheed U; Hassan M; Jawed R; Abbas MB; Yaseen R; Ali Naqvi SA; Rizvi H; Syed M
    Cureus; 2020 Dec; 12(12):e12294. PubMed ID: 33520498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of severe COVID-19 and mortality in patients with established chronic liver disease: a nationwide matched cohort study.
    Simon TG; Hagström H; Sharma R; Söderling J; Roelstraete B; Larsson E; Ludvigsson JF
    BMC Gastroenterol; 2021 Nov; 21(1):439. PubMed ID: 34814851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trends in the Burden of Chronic Liver Disease Among Hospitalized US Adults.
    Hirode G; Saab S; Wong RJ
    JAMA Netw Open; 2020 Apr; 3(4):e201997. PubMed ID: 32239220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the impact of chronic corticosteroid therapy on critical care outcomes of COVID-19 patients with and without history of chronic liver disease.
    Liaquat H; Shupp B; Rollins S; Schneider Y; Matin A
    Sci Rep; 2021 Sep; 11(1):19245. PubMed ID: 34584170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes following SARS-CoV-2 infection in patients with chronic liver disease: An international registry study.
    Marjot T; Moon AM; Cook JA; Abd-Elsalam S; Aloman C; Armstrong MJ; Pose E; Brenner EJ; Cargill T; Catana MA; Dhanasekaran R; Eshraghian A; García-Juárez I; Gill US; Jones PD; Kennedy J; Marshall A; Matthews C; Mells G; Mercer C; Perumalswami PV; Avitabile E; Qi X; Su F; Ufere NN; Wong YJ; Zheng MH; Barnes E; Barritt AS; Webb GJ
    J Hepatol; 2021 Mar; 74(3):567-577. PubMed ID: 33035628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between the concurrence of pre-existing chronic liver disease and worse prognosis in patients with an herb-
    Jing J; Wang RL; Zhao XY; Zhu Y; Niu M; Wang LF; Song XA; He TT; Sun YQ; Xu WT; Yu SM; Wang LP; Guo YM; Bai ZF; Xiao XH; Wang JB
    BMJ Open; 2019 Jan; 9(1):e023567. PubMed ID: 30782709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical characteristics of and outcomes for patients with COVID-19 and comorbid lung diseases primarily hospitalized in a conventional pulmonology unit: A retrospective study.
    Riou M; Marcot C; Canuet M; Renaud-Picard B; Chatron E; Porzio M; Dégot T; Hirschi S; Metz-Favre C; Kassegne L; Ederle C; Khayath N; Labani A; Leyendecker P; De Blay F; Kessler R;
    Respir Med Res; 2021 May; 79():100801. PubMed ID: 33259989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognosis of French COVID-19 patients with chronic liver disease: A national retrospective cohort study for 2020.
    Mallet V; Beeker N; Bouam S; Sogni P; Pol S;
    J Hepatol; 2021 Oct; 75(4):848-855. PubMed ID: 33992699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
    Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
    Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liver manifestations in COVID-19 and the influence of pre-existing liver disease in the course of the infection.
    Guerra Veloz MF; Cordero Ruiz P; Ríos-Villegas MJ; Del Pino Bellido P; Bravo-Ferrer J; Galvés Cordero R; Cadena Herrera ML; Vías Parrado C; Bellido Muñoz F; Vega Rodríguez F; Caunedo Álvarez Á; Rodríguez-Baño J; Carmona Soria I
    Rev Esp Enferm Dig; 2021 Feb; 113(2):103-109. PubMed ID: 33393329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of severe disease and mortality of COVID-19 in patients with Budd-Chiari syndrome: A population-based matched cohort study.
    Krishnan A; Schneider CV; Schattenberg JM; Alqahtani SA
    Liver Int; 2023 May; 43(5):1141-1144. PubMed ID: 36825357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors and outcomes for acute-on-chronic liver failure in COVID-19: a large multi-center observational cohort study.
    Satapathy SK; Roth NC; Kvasnovsky C; Hirsch JS; Trindade AJ; Molmenti E; Barish M; Hirschwerk D; Da BL; Bernstein D;
    Hepatol Int; 2021 Jun; 15(3):766-779. PubMed ID: 33826042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic liver disease related mortality pattern in Northern Pakistan.
    Khokhar N; Niazi SA
    J Coll Physicians Surg Pak; 2003 Sep; 13(9):495-7. PubMed ID: 12971866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. COVID-19 risk, disparities and outcomes in patients with chronic liver disease in the United States.
    Wang Q; Davis PB; Xu R
    EClinicalMedicine; 2021 Jan; 31():100688. PubMed ID: 33521611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.